The three-dimensional printing (3DP) also known as the additive manufacturing (AM), a
novel and futuristic technology that facilitates the printing of multiscale, biomimetic, intricate …

Tissue engineering represents an advanced approach to treating patients who have
suffered tissue or organ loss or failure, with the ultimate goals of tissue restoration and …

While there has been considerable success in the three-dimensional bioprinting of relatively
large standalone filamentous tissues, the fabrication of solid fibers with ultrafine diameters or …

The arterial occlusive disease is one of the leading causes of cardiovascular diseases, often
requiring revascularization. Lack of suitable small-diameter vascular grafts (SDVGs) …

3D bioprinting is transforming tissue engineering in medicine by providing novel methods
that are precise and highly customizable to create biological tissues. The selection of a “cell …

Cardiovascular diseases are mostly associated with narrowing or blockage of blood vessels,
and it is the most common cause of death worldwide. The use of vascular grafts is a …

Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide.
Autografts are gold-standard treatment options. However, their use is hampered by several …

Abstract 3D bioprinting technology is widely used to fabricate various tissue structures.
However, the absence of vessels hampers the ability of bioprinted tissues to receive oxygen …

Biofabrication approaches toward the development of tissue-engineered vascular grafts
(TEVGs) have been widely investigated. However, successful translation has been limited to …

The clinical utility of small-diameter vascular grafts (SDVGs) is limited due to the possibility
of thrombosis and intimal hyperplasia. These features can delay the development of a …